a new multiple-drug protocol consisting of cyclophosphamide , vincristine , prednisone , bleomycin , doxorubicin , and procarbazine , known as cop-blam , was administered to 48 patients with stage iii or iv diffuse histiocytic lymphoma .
C0013089
doxorubicin
C0056273
cop-blam